13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 38 holding rows worth $403,795,000.
- Accession
- 0001493152-20-002299
- Filer
- CIK 1582844
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 38 entries on the cover page, a total value of $403,795,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $403,795,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 607,500 | $62,791,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 500,000 | $47,555,000 | thousands by filing date | put |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 442,500 | $28,068,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 6,040,000 | $27,361,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 1,057,500 | $21,425,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 587,089 | $20,143,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 656,500 | $18,172,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 1,322,500 | $15,235,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 356,000 | $14,628,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 1,625,000 | $12,269,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 917,500 | $12,028,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 590,000 | $11,310,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,825,000 | $9,746,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 197,500 | $9,304,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 387,500 | $8,537,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 508,500 | $8,141,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 910,000 | $7,808,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 38,000 | $7,768,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 810,000 | $6,156,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 187,500 | $5,741,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 2,364,204 | $5,345,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 372,500 | $4,589,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 56,000 | $4,219,000 | thousands by filing date | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 148,000 | $4,037,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 169,000 | $4,036,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 100,000 | $3,431,000 | thousands by filing date | call |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 240,000 | $3,300,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 70,500 | $3,205,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 150,000 | $3,174,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 22,500 | $3,130,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 107,500 | $1,915,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 21,700 | $1,843,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 25,000 | $1,792,000 | thousands by filing date | |
| ACASTI PHARMA INC | 00430K402 | CL A NEW | 620,000 | $1,519,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 35,000 | $1,384,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 100,000 | $1,152,000 | thousands by filing date | call |
| ZAFGEN INC | 98885E103 | COM | 1,000,000 | $1,110,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 40,000 | $428,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-20-002299 | this filing | 2020-02-14 | acceptance time not in the bulk data set |